Generic Drug Supply Faces Pressure Under Trump’s Proposed 100% Tariff
From Bloomberg — Jul 24th, 2026
President Donald Trump proposed imposing a 100% tariff on imported generic drugs starting in 2028, requiring manufacturers to move production to the U.S. or face steep import duties that could rise to 200% in 2029. The plan aims to boost domestic pharmaceutical manufacturing but has raised concerns about higher costs, supply disruptions, and reduced access to low-cost generic medicines.
Spencer Perlman of Veda Partners questioned the proposal's viability, calling the tariffs "impractical and undesirable politically and economically." He suggested the announcement is more likely to serve as a negotiating tool than a policy expected to take effect, as the administration continues to pursue broader pharmaceutical pricing and manufacturing goals.
This excerpt and any accompanying media (including audio, video, or images) are shared under the principles of fair use, for informational and archival purposes only. All rights remain with the original publisher.